Systematic video-assisted mediastinoscopic lymphadenectomy in the treatment of resectable non-small cell lung cancer

Ke Ma, Xiang Wang, Tianpeng Xie, Xiaojun Yang, Ping Xiao, Xiang Zhuang, Qiang LiChinese 2013 · DOI

Abstract

Objective This study was performed to assess the clinical feasibility of video-assisted mediastinoscopic lymphadenectomy in the treatment of resectable lung cancer.Methods Between March 2011 and May 2012,we retrospectively analyzed the data from 56 patients who underwent video-assisted mediastinoscopic lymphadenectomy(VAMLA).In patients receiving tumour resection subsequently,radicality of the previous mediastinoscopic dissection was controlled during thoracotomy.Results Mean operative time of video-assisted mediastinoscopic lymphadenectomy was(42.0 ± 13.5) min(range of 26-86 min).Mean number of resected lymph nodes was 12.4 ± 6.7 (range of 5-24).In video-assisted mediastinoscopic lymphadenectomy,the rates of lymph node dissection of stations 2,4,5,7,8 were 54.5%,92.7%,58.2%,100%,61.8%,respectively,there was no operative mortality and morbility.90.9% patients achieved radical dissection.Conclusion Video-assisted mediastinoscopic lymphadenectomy is a clinically feasible procedure and provides more accurate staging of mediastinal node in lung cancer patients.It also plays an important role in minimal invasive surgery and neoadjuvant therapy. Key words: Carcinoma, non-small-cell lung; Mediastinoscopy; Lymph node excision
BibTeX
@inproceedings{ma2013systematic,
  author = {Ke Ma and Xiang Wang and Tianpeng Xie and Xiaojun Yang and Ping Xiao and Xiang Zhuang and Qiang Li},
  title = {{Systematic video-assisted mediastinoscopic lymphadenectomy in the treatment of resectable non-small cell lung cancer}},
  booktitle = {Chinese},
  year = {2013},
  doi = {10.3760/cma.j.issn.1001-4497.2013.06.017},
}

Loading related content...

Figure